Landec Corporation to Participate in the 23rd Annual ICR Virtual Conference
January 07 2021 - 4:05PM
Landec Corporation (Nasdaq: LNDC), a diversified health and
wellness company with two operating businesses, Curation Foods,
Inc. and Lifecore Biomedical, Inc., announced today that Dr. Albert
Bolles, the Company's President and Chief Executive Officer, and
Jim Hall, Lifecore Biomedical’s President, will be participating in
a fireside chat to discuss Lifecore Biomedical’s unique position as
a specialty CDMO at the 23rd Annual ICR Virtual Conference during
its Healthcare Day on Thursday, January 14, 2021, at 12:15 PM ET.
The fireside chat will be available to all
interested parties through a live audio webcast that can be
accessed via webcast and will be hosted at the “Events &
Presentations” section of the Company's investor relations website:
ir.landec.com. An archived replay of the webcast will also be
available shortly after the live event has concluded.
About Landec Corporation Landec
Corporation (NASDAQ: LNDC) is a leading innovator of
diversified health and wellness solutions with two operating
businesses: Curation Foods, Inc. and Lifecore
Biomedical, Inc. Landec designs, develops, manufactures,
and sells products for the food and biopharmaceutical
industry. Curation Foods is focused on innovating and
distributing plant-based foods with 100% clean ingredients to
retail, club and foodservice channels throughout North
America. Curation Foods is able to maximize product
freshness through its geographically dispersed family of growers,
refrigerated supply chain and patented BreatheWay® packaging
technology. Curation Foods brands include Eat Smart® fresh
packaged vegetables and salads, O Olive Oil &
Vinegar® premium artisan products,
and Yucatan® and Cabo Fresh® avocado products.
Lifecore Biomedical is a fully integrated contract development and
manufacturing organization (CDMO) that offers highly differentiated
capabilities in the development, fill and finish of sterile,
injectable pharmaceutical products in syringes and vials. As a
leading manufacturer of premium, injectable grade Hyaluronic Acid,
Lifecore brings 35 years of expertise as a partner for global and
emerging biopharmaceutical and biotechnology companies across
multiple therapeutic categories to bring their innovations to
market. For more information about the Company, visit Landec’s
website at www.landec.com.
Contact Information:
Investor Relations: Jeff Sonnek
(646) 277-1263 jeff.sonnek@icrinc.com
Landec (NASDAQ:LNDC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Landec (NASDAQ:LNDC)
Historical Stock Chart
From Sep 2023 to Sep 2024